CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

Medtronic stock was down stock was down today after its third-quarter revenue slightly missed the Wall Street analyst consensus.

Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its ...

The developer of the highly successful da Vinci surgical robot, the company has long enjoyed a dominant market position in ...

The massive robot-making, pacemaker-inventing medtech company Medtronic is facing a financial snag: the humble stapler.

The cardiovascular portfolio grew mid-single-digits, with cardiac ablation solutions reporting 22% growth, driven by the Pulse Field Ablation (PFA) products, Affera and PulseSelect. Management ...

Mazzola’s retirement plan comes less than two months after CFO William Kelly left the surgical robot developer.

Medtronic CEO Geoff Martha told investors in November that the company plans to make a submission to the Food and Drug Administration for its Hugo robot ... livestream system that was recently ...

there is plenty of whitespace here for Medtronic. Second, the healthcare giant is developing a robotic-assisted surgery (RAS) device, the Hugo system. This gadget is currently being tested in the ...

Medtronic launched the CD Horizon ModuLeX spinal system for deformity surgery, the devicemaker said Feb. 19. The ModuLeX system works with Medtronic's AiBLE ecosystem for spine surgery and has a ...